Printer Friendly
The Free Library
19,595,263 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Ampersand Medical CEO Peter Gombrich Talks to The Wall Street Transcript.


Business Editors

NOTE: This analyst interview is presented with the aforementioned

company's full knowledge and permission.

NEW YORK--(BUSINESS WIRE)--July 17, 2000

The Wall Street Transcript has published an in-depth interview with Peter Gombrich, CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  of Ampersand The ampersand (&) normally means "and" as in Jones & Company. However, in the computer world, it is used in various ways. In Windows, it is used as a code to precede an underlined character.  Medical (OTC OTC

See: Over-the-counter.


OTC

See over-the-counter market (OTC).
 BB:AMPM.OB), in which he talks at length about the company's future.

The entire 2,900-word interview is available free online at http://www.twst.com/ceos.htm

Gombrich gives an overview of his company, "Ampersand Medical is a biotech diagnostics company. Specifically, we have been looking for Looking for

In the context of general equities, this describing a buy interest in which a dealer is asked to offer stock, often involving a capital commitment. Antithesis of in touch with.
 the means to create a less expensive, quicker way of doing cervical cancer Cervical Cancer Definition

Cervical cancer is a disease in which the cells of the cervix become abnormal and start to grow uncontrollably, forming tumors.
 screening, a replacement for Pap smears Pap smear
 or Papanicolaou smear

Sample of cells from the vagina and cervix of the uterus for laboratory staining and examination to detect genital herpes and early-stage cancer, especially of the cervix. Developed by the Greek-born U.S.
. This system is called InPath and is one of Ampersand's product lines."

Gombrich explains, "The InPath System is a complete solution to the problems of cervical cancer screening. For existing screening programs, like that in the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. , it offers great opportunities to decrease costs, improve accuracy, and expand access. This is critical because upward of more than; above.

See also: Upward
 40% of cases of cervical cancer in the US this year will be in women who have not had a Pap smear for over five years. Outside of the United States, cervical cancer is the number one or number two killer of women. The majority of these women can be saved from this disease if we can establish screening programs in a sensible way. We believe InPath System answers these needs."

Looking forward, Gombrich states, "I think the major element is that we are well positioned to serve a gigantic marketplace. We have a proprietary technology that not only deals with cervical screening, but also can be utilized in screening for other types of cancer, such as lung and GI. We've got a strong management team, and it has a proven track record on execution. We believe a very bright future is ahead."

This interview is part of a 110-page Drug & Medical Supply Distributors Issue available at http://www.twst.com/info/info132.htm or by calling (212) 952-7433.

The Wall Street Transcript is a premier weekly investment publication serving serious long-term investors for over 37 years.

The Wall Street Transcript has launched a new free service where investors can ask Ampersand Medical (or any public company) a question at http://www.qawire.com

The Wall Street Transcript does not endorse the views of any interviewees nor does it make stock recommendations. For subscription information call (800) 246-7673.
COPYRIGHT 2000 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2000, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jul 17, 2000
Words:402
Previous Article:New Amtrak CIO, Robert Galey, Energizes Amtrak's IT Division Using Enterprise Recruiting Solutions from Career Rewards and Paul-Tittle Associates.
Next Article:Sawtek-Digital Filters Help Make Wireless a Reality, The Telecomm Analyst News.
Topics:



Related Articles
Cardiac Pathways CEO William Starling Talks to The Wall Street Transcript.
Cardima CEO Phillip Radlick Talks to The Wall Street Transcript.
Guidant Corporation CEO Ronald Dollens talks to The Wall Street Transcript.
The Wall Street Transcript Publishes Analyst Comments on AmeriSource Health in Drug & Medical Supply Distributors Issue.
ADAC Laboratories' CEO R. Andrew Eckert Talks To The Wall Street Transcript.
Aspect Medical Systems' CEO Nassib Chamoun and CFO J. Neal Armstrong talk to The Wall Street Transcript.
RITA Medical Systems' CEO Barry Cheskin talks to The Wall Street Transcript.
CAS Medical Systems' CEO Louis Scheps Talks to The Wall Street Transcript.
International Remote Imaging Systems' CEO Dr. John A. O'Malley Talks to The Wall Street Transcript.
MonoGen, Inc. Denies Allegations Made by Molecular Diagnostics, Inc. in its November 20, 2003 Press Release.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles